| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min 10^-8 E2 |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
| FOXA1 |
prostate tumor |
Patient: #1 |
Permissive
Robust
|
Homo sapiens |
GSE114385
...
|
MA0148.4
|
| FOXA1 |
prostate tumor |
Patient: #2 |
Permissive
Robust
|
Homo sapiens |
GSE114385
...
|
MA0148.4
|
| FOXA1 |
prostate tumor |
Patient: #3 |
Permissive
Robust
|
Homo sapiens |
GSE114385
...
|
MA0148.4
|
| FOXA1 |
prostate tumor |
Patient: #4 |
Permissive
Robust
|
Homo sapiens |
GSE114385
...
|
MA0148.4
|
| FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: ethanol |
Permissive
Robust
|
Homo sapiens |
GSE80742
...
|
MA0148.4
|
| FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: R1881 |
Permissive
Robust
|
Homo sapiens |
GSE80742
...
|
MA0148.4
|
| FOXA1 |
LNCaP (prostate carcinoma) |
Treatment: Cells were harvested in log phase growth Genotype: wildtype |
Permissive
Robust
|
Homo sapiens |
GSE85558
...
|
MA0148.4
|
| FOXA1 |
LNCaP (prostate carcinoma) |
Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression |
Permissive
Robust
|
Homo sapiens |
GSE85558
...
|
MA0148.4
|
| FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: Cells were harvested in log phase growth Genotype: wildtype |
Permissive
Robust
|
Homo sapiens |
GSE85558
...
|
MA0148.4
|
Showing 10 records in page 344
from 963 pages